In subsequent experiments, where we selectively silenced TET3 expression in four distinct tumor cell lines (BGC-823, HepG2, A549, TPC-1) (Figure 12A), we observed a profound attenuation of multiple malignant phenotypes. Here, TET3 is linked to neoplasm.